Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

BGLC

BioNexus Gene Lab (BGLC)

BioNexus Gene Lab Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BGLC
FechaHoraFuenteTítuloSímboloCompañía
31/05/202414:47Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
31/05/202414:46Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
09/05/202411:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
18/04/202413:52GlobeNewswire Inc.BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareNASDAQ:BGLCBioNexus Gene Lab Corporation
26/01/202415:05Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:BGLCBioNexus Gene Lab Corporation
23/01/202406:55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BGLCBioNexus Gene Lab Corporation
24/07/202310:30GlobeNewswire Inc.BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital MarketNASDAQ:BGLCBioNexus Gene Lab Corporation
20/07/202312:29GlobeNewswire Inc.BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital MarketNASDAQ:BGLCBioNexus Gene Lab Corporation
 Showing the most relevant articles for your search:NASDAQ:BGLC